RxDoctor Payments Data

Michelle Whatley, NP

Family · Royston, GANPI 1891318333

Payments from drug & device makers

$1,396in general payments, 2019–2025

Across 72 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$441
  • AbbVie$210
  • AstraZeneca$121
  • Lilly USA, LLC$96
  • Takeda Pharmaceuticals U.S.A., Inc.$85
  • Axsome Therapeutics, Inc.$74
  • plus $369 from 16 others

What the payments were for

  • Food & beverage$1,396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,396 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$28,349
Medicare patients
218
Services billed
531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PaxlovidNirmatrelvir/Ritonavir34$4,287
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav140$1,252
Lagevrio (Eua)Molnupiravir11$1,016
Cefdinir23$501
Doxycycline Monohydrate31$486
ValacyclovirValacyclovir Hcl13$389
Ondansetron OdtOndansetron62$375
Methylprednisolone63$315
Cephalexin36$294
Albuterol Sulfate HfaAlbuterol Sulfate14$275
Mupirocin42$244
Fluticasone Propionate18$231
Ciprofloxacin Hcl39$196
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst21$178
Amoxicillin35$140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$21$4,28734 claims
MerckLagevrio (Eua)$17$1,01611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.

Other family in Royston

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →